Month: September 2022

Date: 9 September 2022 Release: After closing of Euronext Please open the following link to read the full report including annexes:AttachmentFULL PRESS RELEASE

Follow-up data further demonstrate encouraging signs of clinical anti-tumor activity and a manageable safety and tolerability profile, building on the positive interim data presented at AACR in April Strongest responses seen in testicular cancer patients treated at dose level 2 after lymphodepletion with overall response rate of 57% and a disease control rate of 85%; product candidate recently received Priority Medicines designation by the European Medicines Agency for this indicationMAINZ, Germany, September 9, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today presented positive follow-up data from its ongoing first-in-human Phase 1/2 trial evaluating the safety and efficacy of the Company’s novel CAR-T cell therapy candidate, BNT211, in patients with relapsed or refractory advanced solid tumors. The results demonstrated...

Costa Mesa, CA, Sept. 09, 2022 (GLOBE NEWSWIRE) — Bitech Technologies Corporation [OTCQB: BTTC] (“Bitech” or “Bitech Technologies”), a global technology solution provider dedicated to providing a suite of green energy solutions with a focus in cryptocurrency mining, data centers and other renewable energy initiatives, announced today it has signed a non-binding Letter of Intent (LOI) to enter into a Joint Venture with GreenTek Mining LLC (“GreenTek”) to acquire and manage Bitcoin mining equipment for mining operations at a modular Bitcoin mining center in the state of Oklahoma. According to the LOI, Bitech, which will provide financing of $2.5 million for planned operations, will control 51% of the Joint Venture and plans to select, in collaboration with GreenTek, a suitable green energy technology for this planned advanced mining...

MIAMI BEACH, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that its Chief Executive Officer, Dr. Tiago Reis Marques, will deliver a virtual presentation at the H.C. Wainwright 24th Annual Global Investment Conference, being held from September 12-14, 2022 in New York, as follows: Date:  Monday, September 12, 2022 Time:  7:00AM ET During the conference Pasithea will be participating in virtual 1×1 meetings that can be requested via H.C. Wainwright. A pre-recorded presentation will be made will be accessible via the Company’s website at ir.pasithea.com. About Pasithea Therapeutics Corp. Pasithea Therapeutics...

BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The third cohort consists of five patients with bradykinesia due to Parkinson’s disease receiving an intravenous infusion of a high concentration stem cell treatment. The third and final cohort of the Phase 1 clinical trial was completed on Tuesday, September 6, 2022. About IMAC’s Phase 1 Clinical Trial The Phase 1 clinical trial, consisting of a 15-patient dose escalation safety and tolerability study, is being conducted at three of IMAC’s clinical centers in Chesterfield, Missouri,...

Special Meeting of Enerflex Ltd. Shareholders Set for October 11, 2022 CALGARY, Alberta, Sept. 09, 2022 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (“Enerflex” or the “Company”), a leading supplier of vertically integrated products and services to the global energy industry, is pleased to announce today that it has filed a management information circular and related meeting materials (collectively, the “Circular”) in connection with its upcoming Special Meeting of Shareholders to be held on October 11, 2022 (the “Special Meeting”). In accordance with the requirements of the Toronto Stock Exchange (“TSX”), the Company is asking Enerflex shareholders to consider and approve the issuance of common shares of Enerflex to the holders of common stock of Exterran Corporation (“Exterran”)...

VANCOUVER, CANADA, Sept. 09, 2022 (GLOBE NEWSWIRE) — QUEST WATER GLOBAL, INC. (OTC Pink: QWTR) (“Quest” and/or the “Company”), an innovative water technology company and developer of the solar-powered AQUAtap™ water purification, desalination, and distribution technology, announced today that the Company’s joint venture in the Democratic Republic of Congo (the “DRC”), AQUAtap™ Oasis Partnership SARL (“AQUAtap™ Oasis”), has developed and launched its proprietary AQUAtap™ App, a mobile device application for the payment of clean water at AQUAtap™ Oasis Community Water Centers in the DRC. The launch of the AQUAtap™ App represents a significant milestone for both the Company and AQUAtap™ Oasis. The App can be downloaded in seconds and users can begin buying water immediately, which will allow AQUAtap™ Oasis...

ARLINGTON, Va., Sept. 09, 2022 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a “fireside chat” Q&A session at the 2022 Global Healthcare Conference on Tuesday, September 13, 2022 beginning at 9:05 am ET. The live webcast and replay of the event, as well as any accompanying slide presentation, will be available at ir.priviahealth.com/news-and-events/events-and-presentations. About Privia Health Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Our platform is led by top industry talent and...